Ascendis Pharma EPS Diluted (TTM) Analysis

Ascendis Pharma A/S (ASND)

142.10 +1.93 (+1.38%) USD | NASDAQ | Apr 22, 16:00

142.04 -0.06 (-0.04%) After-Hours: 20:00

EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	-9.276
September 30, 2023	-11.40
June 30, 2023	-11.32
March 31, 2023	-10.52
December 31, 2022	-10.87
September 30, 2022	-9.226
June 30, 2022	-7.907
March 31, 2022	-9.365
December 31, 2021	-8.295
September 30, 2021	-9.304
June 30, 2021	-10.27
March 31, 2021	-9.428
December 31, 2020	-9.475
September 30, 2020	-8.210
June 30, 2020	-6.098
March 31, 2020	-5.333
December 31, 2019	-5.285
September 30, 2019	-4.269
June 30, 2019	-4.622

Date	Value
March 31, 2019	-3.874
December 31, 2018	-3.780
September 30, 2018	-3.996
June 30, 2018	-4.277
March 31, 2018	-4.655
December 31, 2017	-4.171
September 30, 2017	-3.638
June 30, 2017	-3.219
March 31, 2017	-2.784
December 31, 2016	-2.857
September 30, 2016	-2.843
June 30, 2016	-2.373
March 31, 2016	-2.470
December 31, 2015	-1.498
September 30, 2015	-1.333
June 30, 2015	-1.155
March 31, 2015	-0.7302
December 31, 2014	-0.8616
September 30, 2014	-0.206

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (TTM) Range, Past 5 Years

-11.40

Minimum

Sep 2023

-4.269

Maximum

Sep 2019

-8.446

Average

-9.276

Median

Dec 2023

EPS Diluted (TTM) Benchmarks